TradeTrade
Jump to any asset 844 assets, updated daily

Veeva Systems Inc. (VEEV)

Veeva Systems Inc. NYSE

$297.35 -4.280 (-1.42%)
Latest Price
AI Analyst Consensus
Buy
72 / 100
Veeva Systems Inc. (VEEV) is trading at $297.35, showing bullish momentum with its 14-day RSI at 66.93 and trading above its 50-day and 200-day moving averages ($264.97 and $204.00). The company has a strong track record of beating earnings estimates, most recently reporting EPS of $2.35 against an estimate of $2.22, a 5.86% surprise, which drove a 15.2% price increase. This consistent performance underpins a positive outlook, though a moderate sell signal from insider transactions warrants monitoring. Fundamental analysis reveals a company with a profit margin of 29.35% and an operating margin of 29.64%, significantly outperforming sector averages. Its return on equity stands at 14.43%, compared to the sector median of 6.9%. While the price-to-sales ratio of 13.85 is high relative to the sector average of 3.7, the company's strong growth and profitability metrics justify this premium. The debt-to-equity ratio is a negligible 0.02, indicating a very strong balance sheet.

VEEV at a glance

Veeva Systems Inc. (VEEV): Buy, 72/100 on CleaRank's AI score.

  • Trend Up: the price is above both its 50- and 200-day moving averages ($264.97 and $204.00).
  • Insiders Insiders sold $23.6M and made no open-market purchases over the last 18 months.
  • Valuation P/E of 48.4 against 31.9 for the Healthcare sector: a premium to peers (+52%).

As of October 15, 2026, Veeva Systems Inc. (VEEV) trades at $297.35. Wall Street's consensus target is $300.00 across 29 analysts. The 14-day RSI (daily closes) is 67, showing bullish momentum without being overbought, and the price is above its 50-day simple moving average of $264.97.

Figures as of October 15, 2026.

Only on CleaRank

Figures we compute ourselves from VEEV's own price, earnings and insider-filing history. Tap one to see it in context.

VEEV Price Analysis

Market Metrics

Open
$300.14
Day Range
$293.66 to $301.50
Prev Close
$301.63
Volume
1.24M
52-Week Range
$148.05 to $309.32
Market Cap
$48.14B

Peer Benchmarking

Valuation vs Sector (Healthcare)

Performance vs XLV

Sector Position Analysis
Trading at a significant premium to sector peers (+52%), suggesting market expectations for superior growth or market position.

VEEV Financial Performance

Revenue vs. Earnings

Annual

Quarterly

Earnings Reality Check

In the last 2 quarters, VEEV beat the analyst estimate 2 times; the stock fell in the first session after 1 of those beats.
VEEV earnings surprises and the stock's reaction
Report EPS estimate EPS actual Surprise First session 5 sessions
Aug 26, 2026 $2.22 $2.35 +5.86% +15.20% +14.62%
Jun 3, 2026 $2.14 $2.24 +4.67% -0.07% -8.37%

The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.

As of October 15, 2026, VEEV has beaten the analyst EPS estimate in 2 of its last 2 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 26, 2026, came in 5.86% above the estimate and the stock moved +15.20% in the first session.

VEEV Analysis

Company's Health 4/5
12-Month Analyst Target +0.89% above price
Median of 29 analysts (12-month)
$300.00
AI Analyst Consensus Score Buy
Veeva Systems Inc. (VEEV) is exhibiting strong bullish momentum, with its 14-day RSI at 66.9, indicating it is approaching overbought territory but still within a strong upward trend. The stock is trading above its 50-day SMA of $264.97 and its 200-day SMA of $204.00, reinforcing the bullish technical picture. The 20-day EMA at $282.47 also sits below the current price, suggesting near-term upward pressure. Key support levels are defined by the moving averages, with the 50-day SMA at $264.97 and the 200-day SMA at $204.00. Volume on the most recent trading day was 1,239,800, slightly below the average of 1,306,090, but the overall trend remains positive. The MACD at 9.84 further supports the bullish sentiment, indicating a positive divergence.
ProTips
  • Monitor insider selling activity closely, as $23.6 million in sales have been reported recently.
  • Veeva Systems Inc. is trading above its 50-day and 200-day moving averages ($264.97 and $204.00), indicating positive technical momentum.
Key Catalysts
Bullish Consistent Earnings Beats Drive Positive Momentum

Veeva Systems Inc. has a track record of exceeding analyst EPS expectations, most recently with a 5.86% surprise in its latest earnings report, which fueled a 15.2% stock price increase.

Source: Earnings Report
Bullish Strong Revenue Growth Exceeds Sector Average

The company reported 17.6% revenue growth, significantly outpacing the sector median of 8.1%, indicating strong demand for its services.

Source: Company Filings
Bullish Superior Profitability and Balance Sheet Strength

Veeva Systems boasts a profit margin of 29.35% and a negligible debt-to-equity ratio of 0.02, highlighting operational efficiency and financial stability.

Source: Company Filings
Bearish Moderate Insider Selling Signal

Insiders have sold a total of $23.6 million in stock with no reported purchases, indicating a moderate sell signal that warrants investor attention.

Source: Insider Transactions
Market Outlook
The base case scenario for Veeva Systems Inc. (VEEV) anticipates continued growth, supported by its strong market position in healthcare cloud solutions and consistent earnings performance. Analysts project revenue growth of 15.00% for the current year and 12.00% for the next, with an average 5-year annual growth rate estimate of 14.71%. Potential catalysts for upside include further market penetration and new product adoption, which could drive revenue growth beyond current estimates. Conversely, a significant slowdown in growth, increased competitive pressure, or a broader market downturn could pressure the stock. The moderate insider selling also warrants close observation as a potential indicator of future price action, although the company's strong balance sheet and consistent execution mitigate some of these concerns.

Key Statistics

Market Cap 48.14B
P/E Ratio 48.42
EPS (TTM) 6.11
Dividend Yield 0.00%
52 Week High 309.32
52 Week Low 148.05

As of October 15, 2026, VEEV trades at $297.35, with a market value of $48.14B and a P/E ratio of 48.42.

Veeva Systems Inc. (VEEV) trades at a price-to-earnings ratio of 48.42, which is above the sector median of 31.9, suggesting a premium valuation. However, its price-to-sales ratio of 13.85 is significantly higher than the sector average of 3.7, indicating investors are willing to pay a premium for its revenue. This premium is supported by its strong profitability, with a net profit margin of 29.35% and an operating margin of 29.64%, both well above sector medians. The company's return on equity is 14.43%, more than double the sector average of 6.9%. Revenue growth of 17.6% also surpasses the sector median of 8.1%. With a debt-to-equity ratio of 0.02, Veeva Systems maintains a very healthy balance sheet, providing financial flexibility. The current valuation appears justified by its superior growth and profitability metrics compared to industry peers.

Earnings & Growth Analysis

Veeva Systems Inc. (VEEV) demonstrated strong earnings performance in its most recent report, with EPS of $2.35 beating the estimate of $2.22 by 5.86%. This beat contributed to a significant 15.2% increase in the stock price following the announcement. The prior quarter also saw an EPS beat of 4.67%, indicating a consistent pattern of exceeding analyst expectations. Revenue growth for the current quarter is estimated at +15.00% year-over-year, with next year's growth projected at +12.00%.

Key Risks

A moderate sell signal from insider transactions, with $23.6 million in sales versus no reported purchases, warrants attention despite the overall bullish trend. The company's high price-to-sales ratio of 13.85, significantly above the sector average, could expose it to sharper corrections if growth expectations are not met. Competition within the healthcare information services sector remains a persistent risk, requiring continuous innovation and execution.

Technical Indicators i

RSI (14-day) 66.93
MACD (12, 26) 9.84
SMA (50-day) 264.97
SMA (200-day) 204.00
Technical Rating Bullish
RSI
Bullish
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($264.97) above the 200-day SMA ($204.00), price action is firmly bullish above key moving averages.

As of October 15, 2026, with VEEV at $297.35, its 14-day RSI is 66.9 (showing bullish momentum without being overbought), its 50-day simple moving average is $264.97 and its 200-day is $204.00.

Calculated by CleaRank on daily closes as of October 15, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.28
Weak correlation
Nasdaq 100 (QQQ) +0.23
Weak correlation
Bitcoin (BTC) +0.16
Weak correlation
Gold (XAU) -0.01
Weak correlation

As of October 15, 2026, VEEV's 1-year correlation of daily returns is +0.28 with S&P 500 (SPY), +0.23 with Nasdaq 100 (QQQ), +0.16 with Bitcoin (BTC) and -0.01 with gold (XAU).

Check Custom Correlation

How does any other asset move with VEEV? One year of daily closes, Pearson correlation.

Try

VEEV Wall Street View

12-month price targets

Low $180.00 Median $300.00 (+0.9%) High $343.00

Ratings

Buy 20 Hold 8 Sell 1 3 months ago: 22 of 30 buy

Recent rating actions

Recent analyst rating actions on VEEV
Date Firm Action Rating
Aug 28, 2026 Citigroup Maintains Neutral
Aug 27, 2026 Mizuho Maintains Outperform
Aug 27, 2026 BMO Capital Maintains Market Perform
Aug 27, 2026 Baird Maintains Outperform
Aug 27, 2026 Canaccord Genuity Maintains Hold
Aug 27, 2026 TD Cowen Maintains Buy

As of October 15, 2026, 29 Wall Street analysts cover VEEV: 20 rate it a buy or strong buy, 8 a hold and 1 a sell or strong sell. Their 12-month price targets range from $180.00 to $343.00, with a median of $300.00, 0.9% above the price of $297.35.

Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.

VEEV Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Long entry pick an entry style

Conservative
$291.40
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$297.35
Buy at current price
Higher risk, immediate entry

Risk Management

STOP LOSS
$279.75
MAX LOSS
-4.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (66.9) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$305.97
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$320.54
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$335.11
+15% (Conservative)
+12.7% (Aggressive)

These levels come from VEEV's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.

Growth of $10,000

A $10,000 investment in VEEV in October 2016 would be worth about $78,312 today, compared with about $36,237 for the same investment in the S&P 500 benchmark.

Compare with Another Ticker

VEEV Drawdowns & Recovery

Worst fall, last 10 years
-53.9%
August 2021 to June 2026
Recovery
Not yet
still 10.6% below the August 2021 peak
From the 10-year high
-10.6%
highest close, August 2021
1-year holds that gained
69%
of every 1-year window

As of October 15, 2026, VEEV's worst peak-to-trough fall over the last 10 years was -53.9% (August 2021 to June 2026); it is still 10.6% below that peak, and 69% of 1-year holding periods ended with a gain.

From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in VEEV today could grow to about $27,532 by 2036 in the base case, with a 90th-percentile outcome near $132,333 and a 10th-percentile outcome around $5,728. Projections are statistical simulations, not guarantees.

VEEV Stock Price Prediction: 2030

CleaRank's simulation projects a price near $446 for VEEV by 2030 in the base case, from $297 today (1.5x over 4 years). The 10th-percentile path ends near $165. These are outcomes of a Monte Carlo simulation run on VEEV's historical return distribution, not price targets, and they assume no dividends are reinvested.

VEEV simulated price paths by year
Year 10th percentile Base case 90th percentile
2027 $200 $329 $541
2028 $180 $364 $735
2029 $171 $403 $952
2030 $165 $446 $1,203
2031 $163 $493 $1,497

Method: a lognormal simulation of VEEV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.

People Also Watch

VEEV Insider Trading Analysis

Source: TwelveData, from SEC Form 4 filings
▲ Bought
None
No open-market buys
▼ Sold
$23.6M
19 Transactions
● Insiders
17
Active Traders
$ Avg Transaction
$1.2M
Large trades

As of October 15, 2026, VEEV insiders reported 19 open-market sales worth $23.6M and no open-market purchases over the last 18 months; grants and option exercises are not counted.

Recent insider transactions in VEEV
Date Insider Type Shares Value
Oct 2, 2026
RIZZO DANIEL J
Officer
Sell 4.8K $1.3M
Oct 2, 2026
FADDIS JONATHAN W
General Counsel
Grant 803 -
Oct 1, 2026
FADDIS JONATHAN W
General Counsel
Grant 1.6K -
Oct 1, 2026
KONDATH VIPIN
Officer
Grant 168 -
Oct 1, 2026
RIZZO DANIEL J
Officer
Grant 1.7K -
Oct 1, 2026
SCHWENGER THOMAS D
President
Grant 2.9K -
Oct 1, 2026
VAN WAGENER BRIAN
Chief Financial Officer
Grant 1.6K -
Oct 1, 2026
ZUPPAS ELENI NITSA A
President
Grant 2.2K -
Sep 14, 2026
SCHWENGER THOMAS D
President
Sell 1.0K $265.2K
Sep 9, 2026
HUNG PRISCILLA C
Director
Sell 750 $195.8K

Frequently Asked Questions

What is Veeva Systems Inc.'s long-term outlook?
The long-term outlook for Veeva Systems Inc. is positive, with projected revenue growth of 14.71% annually over the next five years. Analysts anticipate EPS to grow from $9.24 in the current year to $10.25 next year, supporting continued expansion.
How has Veeva Systems Inc. performed in recent earnings reports?
Veeva Systems Inc. has consistently beaten earnings estimates. Most recently, they reported EPS of $2.35 versus an estimate of $2.22, a 5.86% surprise, leading to a 15.2% stock price increase. The prior quarter also saw an EPS beat.
What are the key technical indicators for Veeva Systems Inc. stock?
Veeva Systems Inc. shows strong bullish momentum with a 14-day RSI of 66.9, trading above its 50-day and 200-day moving averages ($264.97 and $204.00). The MACD is positive at 9.84, indicating upward price pressure.
How does Veeva Systems Inc. compare to its sector peers?
Veeva Systems Inc. outperforms its Healthcare sector peers with a higher revenue growth rate (17.6% vs 8.1% median) and a significantly higher return on equity (14.43% vs 6.9% median). However, its valuation metrics like P/E and P/S are considerably higher than sector averages.
What are the main risks facing Veeva Systems Inc.?
Key risks include insider selling totaling $23.6 million, a high price-to-sales ratio of 13.85 relative to the sector, and ongoing competition within the health information services industry.
Are insiders buying or selling VEEV?
Selling, on balance. In the last 18 months, VEEV's officers, directors and large holders reported 19 sales worth $23.6M and no open-market purchases. Grants and option exercises are not counted as buying.
What is the analyst price target for VEEV?
As of October 15, 2026, the 29 Wall Street analysts covering VEEV have 12-month targets from $180.00 to $343.00, with a median of $300.00, 0.9% above the current price of $297.35. 20 rate it a buy or strong buy, 8 a hold and 1 a sell or strong sell. Three months ago 22 of 30 rated it a buy.
What is VEEV's biggest drop in the last 10 years?
Veeva Systems Inc. (VEEV)'s worst peak-to-trough fall over the last 10 years was -53.9%, from August 2021 to June 2026. It has not regained that peak yet and is still 10.6% below it. Over the same period, 69% of 1-year holding periods ended with a gain.
What are VEEV's best and worst months?
Over the last 10 years, June has been VEEV's strongest month on average (+8.71%, rising in 8 of 10 years) and December its weakest (-6.28%, rising in 2 of 10 years). Seasonal averages describe the past and do not predict a given year.
How closely does VEEV move with the stock market?
Over the past year VEEV's daily returns were weakly correlated with the S&P 500 (SPY) (+0.28). Nasdaq 100 (QQQ): +0.23; Bitcoin (BTC): +0.16; Gold (XAU): -0.01. A figure near +1 means the two usually move together; near 0 means little relationship.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The stock analysis, trade plans, and AI-generated signals presented for VEEV are for educational and informational purposes only and do not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All trade setups and performance metrics shown are hypothetical, hindsight-based, and simulated. They do not represent actual trades made by CleaRank or its affiliates. Stock prices can be volatile and are subject to market, economic, and company-specific risks. Market data is provided "as-is" and may be delayed by 15 minutes or more. We do not guarantee the accuracy, completeness, or timeliness of any data. You should never invest money you cannot afford to lose. Past performance does not guarantee future results. Consult a qualified financial advisor before making any investment decisions. Analysis generated on October 15, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.